Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2022 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Concerns About Compounded Bioidentical Menopausal Hormone Therapy.
Pinkerton JV. Pinkerton JV. Cancer J. 2022 May-Jun 01;28(3):241-245. doi: 10.1097/PPO.0000000000000597. Cancer J. 2022. PMID: 35594471
Following the release of the Women's Health Initiative data, women began to use compounded bioidentical hormone therapy (cBHT) in the misguided belief of greater safety and efficacy than traditional hormone therapy. ...For women requesting bi …
Following the release of the Women's Health Initiative data, women began to use compounded bioidentical hormone therapy …
A Personal Prospective on Testosterone Therapy in Women-What We Know in 2022.
Donovitz GS. Donovitz GS. J Pers Med. 2022 Jul 22;12(8):1194. doi: 10.3390/jpm12081194. J Pers Med. 2022. PMID: 35893288 Free PMC article.
Hormone replacement therapy continues to be a controversial topic in medicine, with certain narratives regarding safety concerns that are not scientifically established in peer-reviewed literature. ...There is growing evidence to support the use of physiologic doses …
Hormone replacement therapy continues to be a controversial topic in medicine, with certain narratives regarding safety concer …
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG).
Pilnik S, Belardo A, Marchesan LB, Camero-Lascano A, Acuña-San Martín M, Elizalde-Cremonte A, Ojeda E, Manzur A, Chedraui P. Pilnik S, et al. Climacteric. 2025 Oct;28(5):529-536. doi: 10.1080/13697137.2025.2548805. Epub 2025 Sep 8. Climacteric. 2025. PMID: 40919649
Transdermal formulations are preferred. Subcutaneous pellets and compounded "bioidentical" Testosterone are not recommended due to risks of supraphysiological dosing and insufficient evidence (Grade C: Low). ...Treatment with subcutaneous tablets, bioident …
Transdermal formulations are preferred. Subcutaneous pellets and compounded "bioidentical" Testosterone are not recomme …